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ABSTRACT
Background
In January 2012, on the basis of an initial report from a dermatologist, we began to 
investigate an outbreak of tattoo-associated Mycobacterium chelonae skin and soft-
tissue infections in Rochester, New York. The main goals were to identify the extent, 
cause, and form of transmission of the outbreak and to prevent further cases of 
infection.
Methods
We analyzed data from structured interviews with the patients, histopathological 
testing of skin-biopsy specimens, acid-fast bacilli smears, and microbial cultures 
and antimicrobial susceptibility testing. We also performed DNA sequencing, 
pulsed-field gel electrophoresis (PFGE), cultures of the ink and ingredients used in 
the preparation and packaging of the ink, assessment of source water and faucets 
at tattoo parlors, and investigation of the ink manufacturer.
Results
Between October and December 2011, a persistent, raised, erythematous rash in the 
tattoo area developed in 19 persons (13 men and 6 women) within 3 weeks after they 
received a tattoo from a single artist who used premixed gray ink; the highest occur-
rence of tattooing and rash onset was in November (accounting for 15 and 12 pa-
tients, respectively). The average age of the patients was 35 years (range, 18 to 48). 
Skin-biopsy specimens, obtained from 17 patients, showed abnormalities in all 17, with 
M. chelonae isolated from 14 and confirmed by means of DNA sequencing. PFGE 
analysis showed indistinguishable patterns in 11 clinical isolates and one of three 
unopened bottles of premixed ink. Eighteen of the 19 patients were treated with 
appropriate antibiotics, and their condition improved.
Conclusions
The premixed ink was the common source of infection in this outbreak. These find-
ings led to a recall by the manufacturer. 
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Since 2003, a growing number of pub-lished case reports have linked tattooing with localized infections due to atypical 
mycobacteria.1-13 Mycobacterium chelonae is a rapidly 
growing form of nontuberculous mycobacteria; 
overall, it is an uncommon cause of cutaneous 
infections.14 We describe an investigation of an 
outbreak involving 19 persons with presumed 
M. chelonae infection after receiving a tattoo from 
a single artist who used a premixed ink that was 
contaminated before distribution. Previous out-
breaks were associated with dilution and contam-
ination of ink at the tattoo parlor.
Methods
Index Patient
On January 4, 2012, we and colleagues at the 
Monroe County Department of Public Health be-
gan investigating an outbreak on the basis of a 
report from a dermatologist of the development 
of a persistent granulomatous rash on the arm of 
a person who had received a tattoo on that area 
in October 2011. This index patient was a previ-
ously healthy 20-year-old man who had a history 
of multiple tattoos without any health problems. 
He was treated unsuccessfully with glucocorti-
coids by his primary care provider before being 
referred to a dermatologist. Histopathological ex-
amination and culture of a biopsy specimen con-
firmed the presence of M. chelonae.
Epidemiologic Investigation
After the interview with the index patient, inves-
tigators at the Monroe County Department of 
Public Health learned that similar reactions had 
developed in other persons who had obtained tat-
toos from the same artist at the same tattoo par-
lor. During a site visit, investigators interviewed 
the tattoo artist and learned that since May 2011, 
he had been using a new, hand-blended, diluted 
black ink (gray wash) that contained pigment, dis-
tilled water, witch hazel, and glycerin. Gray wash is 
used to achieve shading and a three-dimensional 
quality in tattoos; it is a prominent component of 
portrait and photography tattoos, which are cur-
rently popular.
According to the artist, the manufacturer di-
luted the black ink with distilled water before 
packaging and shipping the ink. This premixed ink 
was prepackaged in three dilution strengths per 
set: a 30%, or light, wash (i.e., greatest dilution); 
a 60%, or medium, wash (i.e., intermediate dilu-
tion); and a 90%, or dark, wash (i.e., least dilution). 
The tattoo artist originally purchased the ink in 
April 2011 at a tattoo trade show in Arizona, and 
he later ordered an additional supply. The prod-
uct labeling contained no lot number or other 
unique manufacturing identification. He stopped 
using the premixed ink in December 2011.
To identify cases of infection, a number of steps 
were taken. First, a regional pathology labora-
tory used by many dermatologists was alerted to 
report any cases of ink-associated granulomatous 
reactions. Second, a list of patrons who were 
tattooed between May and December 2011 was 
obtained from the tattoo artist. The artist did not 
maintain detailed records that included the type 
of ink that was used with each patron. Third, all 
local tattoo parlors within Monroe County were 
identified, contacted by telephone, and queried 
about ink products used in their establishments 
as well as any reports of rashlike illnesses. No 
other parlor used this premixed ink, and no rash-
like illnesses were reported. Finally, exposed pa-
trons were contacted by telephone and inter-
viewed, with the use of a standard questionnaire, 
about receiving a tattoo and any subsequent rash-
like illness.
An environmental health assessment suggest-
ed that best practices were generally observed at 
the parlor where the index patient received his tat-
too, and no concerns about hygiene were noted. 
In particular, the artists used sterile instruments, 
wore clean disposable gloves, poured ink into 
single-use containers, and provided appropriate 
aftercare to the tattooed site. Importantly, no di-
lution or mixing of inks at the parlor occurred, 
and the artist avoided contamination of ink from 
tap water at the facility. These practices were con-
firmed by all interviewed patrons.
The Food and Drug Administration (FDA) in-
spected the Arizona-based manufacturer and dis-
tributor of the ink. The FDA collected samples of 
ink and of the ingredients used in its prepara-
tion and packaging, and the Centers for Disease 
Control and Prevention (CDC) cultured them.
The clinical findings in all but two patients 
were evaluated at the University of Rochester 
Medical Center; of the two patients with find-
ings that were not evaluated, one had follow-up 
in another state and another declined evaluation 
and treatment. Patients were evaluated by der-
matologists, who performed skin biopsies of the 
The New England Journal of Medicine 
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tattooed lesions; tissue specimens were then sent 
for histologic and microbiologic analysis. Patients 
were referred to an infectious-disease expert for 
follow-up care and offered empirical treatment 
with appropriate antimicrobial agents.
Histologic and Microbiologic Investigation
Laboratory investigations were conducted at the 
University of Rochester Medical Center, the Wads-
worth Center of the New York State Department 
of Health, and the CDC. Samples from clinical 
isolates, one opened bottle of 60% premixed gray 
ink wash and three unopened bottles (one con-
taining 30% wash, one containing 60% wash, 
and one containing 90% wash), and water and 
swabs from faucets (biofilm) were submitted for 
various microbiologic tests, including acid-fast 
bacilli smears, cultures and antimicrobial sensi-
tivity profiles, DNA sequencing, and pulsed-field 
gel electrophoresis (PFGE), according to stan-
dard protocols.15-20
Results
Epidemiologic Investigation
In this outbreak of M. chelonae infections associat-
ed with tattoos, 19 cases were identified: 14 con-
firmed cases, 4 probable cases, and 1 suspected 
case (see Table S1 in the Supplementary Appen-
dix, available with the full text of this article at 
NEJM.org). On the basis of a list of 167 patrons 
provided by the tattoo artist, the attack rate in-
creased from zero during the period from May 
through August to a peak of 65% in November 
(Fig. 1). Rashes were confined to areas of the skin 
tattooed with the premixed gray ink (Fig. 2). The 
average age of the 13 men and 6 women with 
M. chelonae infection was 35 years (range, 18 to 48).
Histologic and Microbiologic Investigation
Biopsy specimens were obtained from 17 of the 
19 patients: sparse lymphohistiocytic infiltrates 
in the upper dermis were observed in 12 speci-
mens, granulomas in 5, and acid-fast organisms 
in 2 (Fig. S1 in the Supplementary Appendix). 
M. chelonae was isolated in 14 of the 17 tissue 
specimens and confirmed by DNA sequencing.
Antimicrobial susceptibility studies for atypi-
cal mycobacteria are not routinely performed in 
the United States; however, these studies were 
performed in two patients. In the first patient, 
M. chelonae was sensitive to clarithromycin, doxy-
cycline, and linezolid; had intermediate sensitiv-
ity to ciprofloxacin; and was resistant to cefoxitin. 
In the second patient, M. chelonae was sensitive to 
clarithromycin and doxycycline, had intermediate 
sensitivity to linezolid, and was resistant to cipro-
floxacin and cefoxitin.
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Figure 1. Epidemic Curve for Tattoo-Associated Infections and Attack Rate among 167 Patrons of a Tattoo Parlor, 
According to Month of Occurrence, 2011.
The onset of the rash occurred 1 to 3 weeks after receipt of the tattoo. In one case, tattooing occurred in September 
or October and the rash began in October. 
The New England Journal of Medicine 
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The CDC results confirmed the isolation of 
M. chelonae and showed an indistinguishable PFGE 
pattern in 11 clinical isolates and one of three 
unopened bottles of ink (i.e., the 30% gray wash) 
(Fig. S2 in the Supplementary Appendix). M. chelo-
nae was not isolated from the water or faucet in 
the tattoo parlor.
Infection-Control Measures
We collected the remaining bottles of premixed 
ink from the tattoo parlor. We also provided infor-
mation and education to both tattoo artists and 
patrons at a large tattoo trade show hosted in 
Rochester, New York. The materials provided in-
cluded information on New York State law, which 
bans tattooing of persons younger than 18 years 
of age, regardless of whether parental consent is 
given; tattooing best practices, including the use 
of sterile products and aseptic techniques as well 
as appropriate aftercare; risks associated with 
tattooing; signs of a reaction from a tattoo; and 
steps to be taken if a reaction to a tattoo occurs.
The CDC issued a nationwide alert about the 
outbreak. The manufacturer voluntarily recalled 
the ink. Appropriate antimicrobial therapy (mac-
rolides at first, based on the recommendations 
from relevant prior case reports, and then mac-
rolides, doxycycline, or both, once sensitivities 
were available) was initiated in 18 of the 19 pa-
tients, and their condition improved, although the 
speed of recovery in each patient varied.
Discussion
In this outbreak in Rochester, New York, cutane-
ous M. chelonae infection developed in 19 patrons 
of a tattoo parlor, with culture confirmation in 
14, after tattooing performed with the use of a 
premixed gray ink manufactured in Arizona. The 
epidemiologic, histologic, and microbiologic evi-
dence implicated the ink, not the practices of the 
tattoo parlor, as the common source of infection.
Previous studies have linked M. chelonae to 
other procedures.20-24 However, only in the past 
decade have cutaneous infections with nontuber-
culous mycobacteria been associated with tattoo-
ing, with Wolf and Wolf describing the first case 
in 2003.1 According to their report, cultures were 
negative, but polymerase-chain-reaction analysis 
confirmed the diagnosis; they were unable to con-
firm the mycobacterial species. Goldman et al. 
reported on a case series involving 48 patients 
with M. chelonae infections linked to tattooing in 
France.5 In that outbreak, M. chelonae was isolated 
in 13 patients; no PFGE analysis was performed. 
M. chelonae was isolated from opened, but not 
unopened, bottles of ink. In the United States, 
Drage et al. described an outbreak of M. chelonae 
infections involving 6 patients with tattoos.4 In 
that case series, cultures confirmed M. chelonae 
infection in 3 patients.
Previous studies, although not testing specifi-
cally for mycobacteria, have shown that unopened 
stock bottles of tattoo ink may contain bacteria 
that are pathogenic in humans despite claims of 
sterility.25 In the current study, mycobacteria were 
detected in both opened and unopened bottles of 
ink. These findings suggest that mycobacteria may 
be another potential contaminant, especially if the 
ink is diluted with nonsterile water before distri-
bution.
A major limitation of this investigation was the 
lack of detailed records on the patrons of the tat-
too parlor, which affected the assessment of ex-
posure. The tattoo artist was uncertain about 
which patron received which batch of ink and 
about the dilution of the premixed gray ink used. 
It seems reasonable to suppose that the first batch 
was used during the earlier exposure period, since 
no cases of infection developed until October; 
this suggests that only the second batch was con-
Figure 2. Typical Rash Associated with Mycobacterium 
chelonae Infection.
The New England Journal of Medicine 
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taminated. The likelihood of overlooked cases was 
minimized through the active surveillance efforts 
undertaken by the public health department.
Our findings have at least two implications. 
First, since tattooing has become more popular 
over time, the incidence of cutaneous mycobac-
terial infections may be underestimated, given 
the lack of both routine testing and mandated 
reporting. Second, although contamination in tat-
too parlors has been implicated in previous out-
breaks, our investigation of this outbreak shows 
that premixed ink contaminated before distribu-
tion poses a risk to public health, which may sug-
gest the need for enhanced oversight of not just 
tattooing but also the inks used in tattooing to 
ensure public safety.
The findings and conclusions in this report are those of the 
authors and do not necessarily represent the official position of 
the Centers for Disease Control and Prevention or the Agency for 
Toxic Substances and Disease Registry.
Disclosure forms provided by the authors are available with 
the full text of this article at NEJM.org.
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